Loading...

Loading...

UNAM Breast Cancer Vaccines Move Toward Human Trials
By MBN Staff - Wed, 12/31/2025 - 12:16
UNAM researchers developed therapeutic breast cancer vaccines with preclinical success, clearing the path for future human trials.
https://mexicobusiness.news/tag/cancer-research
More Health
INMEGEN Expands Genomic Research With New Sequencing Technology
By MBN Staff - Mon, 03/24/2025 - 10:23
INMEGEN incorporates a high-capacity sequencer to improve genomic research, early disease detection, and pandemic preparedness in Mexico.
The Next Leap in Personalized Cancer Care
By - Tue, 03/11/2025 - 08:30
From monoclonal antibodies to the evolution toward Antibody Drug Conjugates, Luis Alberto Velez looks at the future of cancer care.

HIV, H5N1, Sexual Violence: The Week in Health
By Sofía Garduño - Thu, 12/05/2024 - 10:00
This week, the World Health Organization called for stronger H5N1 surveillance, while Mexico's authorities joined forces to fight sexual violence.
GE Healthcare's AI Lab Advances Tools for Enhanced Patient Care
By MBN Staff - Wed, 10/30/2024 - 10:54
GE Healthcare's AI Innovation Lab is set to accelerate the development of AI tools designed to enhance healthcare efficiency.

 Global Breast Cancer Initiative: The Good, Bad, and Challenging
By Guillermo Pepe - Thu, 10/10/2024 - 16:00
The Global Breast Cancer Initiative has the potential to save millions of lives, but only if we act with urgency, writes Guillermo Pepe.

IMSS Advances Pediatric Cancer Care Amid Policy Gaps
By Anmol Motwani - Wed, 10/02/2024 - 09:58
IMSS is improving pediatric cancer care with precision treatments, but a policy partnership is needed for a holistic approach.

Protein Degraders: A New Frontier in Cancer Treatment
By Anmol Motwani - Thu, 09/12/2024 - 10:51
Arvinas' vepdegestrant, a pioneering protein degrader, shows up to 97% efficacy in tumor reduction, poised for FDA approval by 2025.
Global Cancer Deaths in Men Projected to Nearly Double by 2050
By MBN Staff - Fri, 08/16/2024 - 16:48
Study projects a 93% increase in global cancer deaths among men by 2050, highlighting urgent need for improved health infrastructure and access.
Faster Approvals Could Hasten New Drug Introduction in LATAM
By Sofía Garduño - Tue, 07/16/2024 - 17:04
Shortening regulatory approval timelines would benefit the industry and help bring new drugs to market more quickly, says PPD’s Marlene Llópiz Avilés